尼塔佐胺和乌姆贝利费龙改善了伊米基莫德诱导的牛皮在Balb/C小鼠
Japneet Singh Purewal1, Maheshkumar Borkar2, Gaurav M Doshi1
1SVKM's Dr Bhanuben Nanavati College of Pharmacy, Department of Pharmacology, V.M. Road, Vile Parle (W), Mumbai, India.
Bioorganic chemistry
|April 2, 2025
概括
尼塔佐克桑化物 (NTZ) 和乌姆贝利费龙 (UMB) 在治疗牛皮 (Pso) 中表现有前途. 这些化合物在小鼠模型中降低了关键的炎症标志物和氧化应激,这表明它有可能成为新的牛皮治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮 (Pso) 病变包括信号转换器和转录激活器 (STAT) 3信号和氧化应激.
- 在牛皮中,STAT3和核因子kappa-B (NF-κB) 途径受到上调.
- 尼塔佐化物 (NTZ) 抑制STAT3,而贝利费龙 (UMB) 具有抗氧化和抗炎性质,抑制NF-κB.
研究的目的:
- 研究NTZ和UMB作为牛皮治疗药物的潜力.
- 评估NTZ和UMB在小鼠皮病模型中的疗效.
主要方法:
- 在Balb/c小鼠中使用IMQ诱导了牛皮.
- 临床PSO严重程度通过PASI,皮肤厚度,脏测量和组织学来评估.
- 量化了IL-17,TNF-α,STAT3,NF-κB,超氧化物转化酶 (SOD) 和催化酶 (CAT) 的水平.
- 在体分析中,研究了NTZ和UMB与STAT3.3的相互作用.
主要成果:
- 在小鼠中,NTZ和UMB治疗显著改善了临床Pso特征.
- 治疗降低了IL-17,TNF-α,STAT3和NF-κB的水平.
- 在接受治疗的组中观察到高水平的抗氧化酶SOD和CAT.
- 在-silico研究提供了对药物向相互作用的见解.
结论:
- NTZ和UMB对牛皮有显著的治疗潜力.
- 这些化合物有效调节与Pso.有关的关键炎症和氧化应激通路.
- 需要进一步研究NTZ和UMB作为Pso治疗方法.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
110
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
110
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109


